Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Paget's Disease of Bone in China
NCT00774020Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in Paget's disease of bone, sponsored by Novartis. Started Oct 2008; status: completed.
02
Drugs
zoledronic acid
03
Conditions
Paget's disease of bone
Beyond the preview
Go deeper on NCT00774020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00774020.